$71.50
▲ +0.1% Today
as of Jul 22, 16:48 ET
Last 30 days
Recent Press Releases & News
mixed
▲ 2
● 22
▼ 0
Dexcom Insider Sold Shares Worth $2,041,999, According to a Recent SEC Filing
Are Medical Stocks Lagging DexCom (DXCM) This Year?
Truist Adjusts Price Target on DexCom to $87 From $80, Maintains Buy Rating
Overview
52-week range
$54
$90
48% of range
Avg surprise (last 2)
+1.8%
Avg reaction (last 1)
-1.6%
0% positive
Latest IV / EM
78%
EM ±9.8% · $71 · Jul 31
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Mar 31, 2026 | Mar 2026 | $0.51 | — | — | — | — | financials |
| Tue Sep 30, 2025 | Sep 2025 | $0.70 | — | — | — | — | financials |
| Wed Jul 30, 2025 | Jun/2025 | $0.48 | $0.45 | +6.7% | — | — | earnings |
| Thu May 1, 2025 | Mar/2025 | $0.32 | $0.33 | -3.0% | — | -1.6% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $0.34 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $0.35 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $0.36 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $0.29 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $0.28 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Thu Jul 30, 2026 | Jun/2026 | AMC | $0.61 | $0.48 | +27.1% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | $750M | — | $731M | $689M | $589M | — | $594M | $627M |
| Operating income | $255M | — | $242M | $213M | $134M | — | $152M | $158M |
| Net income | $200M | — | $284M | $180M | $105M | — | $135M | $144M |
| EPS (diluted) | $0.51 | — | $0.70 | $0.45 | $0.27 | — | $0.34 | $0.35 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $1.12B | $918M | $1.84B | $1.16B | $905M | $606M | $621M | $939M |
| Inventory | $694M | $629M | $604M | $571M | $538M | $543M | $586M | $570M |
| Total current assets | $4.33B | $4.03B | $5.22B | $5.03B | $4.55B | $4.30B | $4.26B | $4.85B |
| Total assets | $6.63B | $6.34B | $7.50B | $7.33B | $6.75B | $6.48B | $6.35B | $6.80B |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $3.68B | $3.59B | $4.77B | $4.75B | $4.49B | $4.38B | $4.37B | $4.36B |
| Total equity | $2.96B | $2.75B | $2.73B | $2.57B | $2.27B | $2.10B | $1.98B | $2.43B |